Breakthrough Obesity Drugs. Could dieting become obsolete? Carlos Martinez Sagasta In the past 50 years, the prevalence of obesity has tripled. Being significantly overweight increases the chances of developing various health issues like type 2 diabetes, heart disease, and several malignancies. The need for the creation of efficient obesity treatments is growing as obesity rates rise. New hormone-mimicking pharmaceuticals may reduce hunger and encourage weight loss regarding the advancement and possibility of novel treatments for obesity. It may reduce the cause of experiencing emotions of guilt and the stigma associated with being overweight. GLP-1 receptor agonists, which have been biochemically designed to increase potency and have a sustained effect, are successfully used in clinical settings to treat type-2 diabetes. The GLP-1 analogue Semaglutide was initially licensed by the US FDA to treat type 2 diabetes, but was later approved as a medication to treat obesity. In a...
News and Innovations in Health and Quality of Life